Targeting Angiogenesis and HGF Function Using an Adenoviral Vector Expressing the HGF Antagonist NK4 for Cancer Therapy
Open Access
- 1 February 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (2) , 177-185
- https://doi.org/10.1006/mthe.2002.0533
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factorOncogene, 1998
- Potentiated Angiogenic Effect of Scatter Factor/Hepatocyte Growth Factor via Induction of Vascular Endothelial Growth FactorCirculation, 1998
- HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factorFEBS Letters, 1997
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Emerging Multipotent Aspects of Hepatocyte Growth FactorThe Journal of Biochemistry, 1996
- Scatter factor induces blood vessel formation in vivo.Proceedings of the National Academy of Sciences, 1993
- Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyteBiochemical and Biophysical Research Communications, 1990
- Molecular cloning and expression of human hepatocyte growth factorNature, 1989
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986